Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Arq. bras. neurocir ; 41(1): 19-25, 07/03/2022.
Article Dans Anglais | LILACS | ID: biblio-1362069

Résumé

Introduction Vagal nerve stimulation (VNS) is an adjuvant therapy used in the treatment of patients with refractory epilepsy who are not candidates for resective surgery or who have limited results after surgical procedures. Currently, there is enough evidence to support its use in patients with various types of epilepsy. Therefore, the present study was conducted to explore the possibility of optimizing therapy by reducing the consumption of the system's battery. Methods The prospective and double-blind analysis consisted in the evaluation of 6 patients submitted to VNS implantation for 3 months, followed by adjustment of the stimulation settings and continuity of follow-up for another month. The standard protocol was replaced by another with a frequency value of 20 Hz instead of 30 Hz to increase battery life. The safety of this procedure was evaluated through the assessment of two main variables: seizures and side effects. Results The stimulation at 20 Hz showed 68% reduction in the incidence of seizures (p»0.054) as well as low incidence of side effects. Conclusion The present study suggests that the reduction of the stimulation frequency from 30 to 20 Hz is a safe procedure, and it does not compromise the effectiveness of therapy.


Sujets)
Humains , Mâle , Femelle , Enfant d'âge préscolaire , Enfant , Adolescent , Crises épileptiques/thérapie , Nerf vague/anatomie et histologie , Stimulation du nerf vague/effets indésirables , Épilepsie pharmacorésistante/thérapie , Qualité de vie , Crises épileptiques/prévention et contrôle , Locus ceruleus , Interprétation statistique de données , Résultat thérapeutique , Stimulation du nerf vague/méthodes , Neurostimulateurs implantables
SÉLECTION CITATIONS
Détails de la recherche